PRESS-RELEASE ·Filed Aug 9, 2026

RDNT

RadNet, Inc.
MIXED
Impact 6/10
Horizonweeks Processed1mo ago WireGlobeNewswire
Press release: earnings
Actionable Insight ◆ Mixed

The revenue beat and raised guidance support the growth thesis, but the GAAP EPS miss and declining adjusted EPS warrant caution. Watch for Digital Health margin progression and integration of recent acquisitions; the raised FCF guidance suggests improving cash generation. The stock may trade on the revenue/guidance strength versus the EPS disappointment.

DirectionMixed
Confidencehigh
Horizonweeks
Latest settled — T+20d ⚠ clustered
RDNT ▼ -6.87% at T+20d
NEUTRAL call ✗ call lost -6.87% · α vs SPY -5.96% · entry $77.28 → $71.97
Next anchor: T+60d in 4w
Latest observation: T+38 -7.38% FF3 residual α
Entry anchored
Aug 7, 07:53 PM ET
via 1-min bar
T+1d
-1.22%
call -1.22% · α -0.90%
$76.34
settled 8w ago
T+5d
-1.75%
call -1.75% · α -1.70%
$75.93
settled 7w ago
T+20d
-6.87%
call -6.87% · α -5.96%
$71.97
settled 28d ago
T+60d
—
call — · α —
—
in 4w

Price Chart

Loading chart...

Executive Summary

RadNet reported Q2 2026 revenue of $622.7M (+25% YoY), beating consensus of $609.3M, but GAAP EPS of $0.10 missed the $0.20 estimate by 50%. The company raised full-year Imaging Center guidance for revenue, Adjusted EBITDA, and Free Cash Flow, while Digital Health ARR surged 97% YoY to $105.5M. The mixed results reflect strong top-line growth and a favorable mix shift toward advanced imaging, offset by GAAP earnings pressure from acquisition costs and Digital Health investments.

Key Financial Metrics

EPS
$0.10
est $0.20 · -50.0%
Revenue
$622.7M
est $609.3M · +2.2% · +25.0% YoY
Rating
miss
Guidance
$2,370M - $2,420M
raised

Key Facts

  • Q2 2026 revenue $622.7M (+25% YoY) vs consensus $609.3M (beat by 2.2%)
  • GAAP diluted EPS $0.10 vs consensus $0.20 (miss of 50%)
  • Adjusted EBITDA $99.7M (+22.7% YoY), a quarterly record
  • Digital Health ARR $105.5M at June 30, 2026, up 97.2% YoY and 8.9% sequentially
  • Imaging Center guidance raised: revenue $2,370-$2,420M, Adj. EBITDA $345-$358M, FCF $115-$125M
  • Digital Health segment revenue $32.4M (+56.5% YoY) but Adj. EBITDA declined to $2.5M from $3.4M due to growth investments
  • Advanced imaging mix improved to 29.9% of procedural volumes (up 238 bps YoY)
  • Cash balance $726.3M; Net Debt to Adj. EBITDA ratio 1.8x

Financial Impact

Revenue beat by ~$13.4M (2.2%) and guidance raised by $15M at midpoint; GAAP EPS miss of $0.10 vs $0.20 consensus represents a $0.10 shortfall.

revenueepsadjustedEbitdaarrguidance

Risk Factors

  • Digital Health segment investments may continue to pressure near-term margins and GAAP profitability
  • Integration of $315.7M in acquisition spending during H1 2026 could dilute returns if synergies lag
  • Debt increased to $1.33B (net of cash) from $1.06B at year-end 2025, raising interest expense risk

Market Snapshot

Exchange
Nasdaq
Sector
Services-Medical Laboratories
Analyst Consensus
93% bullish (14 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3341500
14 reports for RDNT
Performance horizon
50% Hit rate 3 of 6 directional calls best @ T+60▲ +26.65%Jun 25, 2026
Filters
Rows
Reports for RDNT — sortable, filterable
TypeNow
Aug 10, 2026
7w ago
8-K
MIXED ★ 6/10
$77.28 $71.97▼ −6.87%▼ −5.96%$69.93 (−9.51%)
Aug 9, 2026
7w ago
Press Release
MIXED ★ 6/10
$77.28 $71.97▼ −6.87%▼ −5.96%$69.93 (−9.51%)
Jun 25, 2026
14w ago
Press Release
BULLISH ★ 5/10
$60.01 $60.98▲ +1.62%▲ +1.09%$69.93 (+16.53%)
Jun 10, 2026
16w ago
8-K
NEUTRAL ★ 5/10
$58.20 $65.94▲ +13.30%▲ +11.41%$69.93 (+20.15%)
Jun 3, 2026
17w ago
8-K
NEUTRAL ★ 4/10
$51.87 $68.75▲ +32.54%▲ +33.54%$69.93 (+34.82%)
May 11, 2026
20w ago
8-K
MIXED ★ 6/10
$55.90 $56.18▲ +0.50%▲ +0.81%$69.93 (+25.10%)
May 10, 2026
20w ago
Press Release
BULLISH ★ 7/10
$55.90 $56.18▲ +0.50%▲ +0.81%$69.93 (+25.10%)
Apr 28, 2026
22w ago
Press Release
BULLISH ★ 7/10
$57.89 $53.84▼ −7.00%▼ −12.45%$69.93 (+20.80%)
Apr 20, 2026
23w ago
DEFA14A
NEUTRAL ★ 3/10
$57.51 $54.17▼ −5.81%▼ −10.72%$69.93 (+21.60%)
Mar 11, 2026
29w ago
Press Release
NEUTRAL ★ 3/10
$59.78 $55.43▼ −7.28%▼ −9.25%$69.93 (+16.98%)
Showing 10 of 14

US Market Status

Market Closed — Opens Mon (39h 28m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Aug 9, 2026